Wells Fargo analyst John Kilichowski raised the firm’s price target on National Health Investors (NHI) to $85 from $80 and keeps an Equal Weight rating on the shares. The firm says that despite a few high-profile exceptions, most REITs delivered Q3 2025 earnings and outlooks reflecting healthy operating conditions despite macro and labor market concerns.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NHI:
- National Health Investors price target raised to $90 from $88 at BofA
- NHI Earnings Call: Growth Amidst Challenges
- National Health Investors Reports Strong Q3 2025 Results
- Strong Financial Performance and Strategic Acquisitions Justify Buy Rating for National Health Investors
- National Health Investors Board Member Announces Departure